TumorGenesis Inc. specializes in media that help cancer cells grow outside the patient’s body and retain their DNA/RNA and proteomic signatures, providing researchers with a tool to expand and study cancer cell types found in tumors of the blood and organ systems of all mammals, including humans. This platform, along with other proprietary FDA-approved technologies from Helomics, is used to fuel unique and more clinically actionable data for our predictive models.
Let us tell you about TumorGenesis.
TumorGenesis currently has a living library of ovarian cancer cell lines that represent most of the ovarian cancer found around the world today.
What problems do we solve?
TumorGenesis makes living tumors readily available to researchers.